Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver Toxicity

Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver Toxicity

<p>Abstract</p> <p>Background</p> <p>in HIV-infected patients with HCV-related chronic hepatitis, liver impairment and drug toxicity may substantially reduce the number of possible therapeutic options.</p> <p>Case Description</p> <p>we here descr...

Full description

Bibliographic Details
Main Authors: Ortu F, Weimer LE, Floridia M, Manconi PE
Format: Article
Language:English
Published: BMC 2010-02-01
Series:European Journal of Medical Research
Subjects:
HIV/HCV
antiretroviral treatment
raltegravir
tenofovir
emtricitabine
chronic active hepatitis
Online Access:http://www.eurjmedres.com/content/15/2/81

Internet

http://www.eurjmedres.com/content/15/2/81

Similar Items